About
Products
Knolens
KnolScapes
Knolens
Knolens SLR
Knolens
KnolQuest
Knolens
Edge
Knolens
DataNexus
Platform
Solutions
KnolSights
Experience Knolens
Nutshell Therapeutics Receives FDA Clearance for Phase 1 Trial of NTS071
Nutshell Therapeutics announced that the US FDA has cleared its Investigational New Drug (IND) application for NTS071, an oral, small molecule alloste...
Copyright © 2025. All rights reserved
About
Terms of Service
Privacy Policy
Home/
KnloSights/
Clinical Trial Updates/
Nutshell Therapeutics Receives FDA Clearance for Phase 1 Trial of NTS071